BioSource International
This article was originally published in The Gray Sheet
Executive Summary
Manufacturer of immunological reagents, test kits and oligonucleotides for biomedical research withdraws planned follow-on offering of 4 mil. shares "due to recent market conditions," the firm announces May 4. The Camarillo, California company had filed a registration statement for the offering with the Securities and Exchange Commission on March 22 (1"The Gray Sheet" April 3, p. 22)